RECRUITING

Integration of Neurocognitive Biomarkers Into a Neuro-Oncology Clinic

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is prospective observational registry study that will assess 1) if the neurocognitive function app (Brainlab Cognition) can be used in a widespread neuro-oncology clinic setting and 2) if patient reported quality of life parameters can be obtained electronically and integrated into clinic.

Official Title

Integration of Neurocognitive Biomarkers Into a Neuro-Oncology Clinic

Quick Facts

Study Start:2021-11-30
Study Completion:2027-11
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05504681

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. All adult (18+) patients with central nervous system (CNS) tumors, both primary brain malignancies and brain metastases, treated with radiotherapy (partial brain, stereotactic radiosurgery, stereotactic fractionated radiotherapy, or whole-brain radiotherapy), surgery, and/or antineoplastic therapy and followed thereafter at Miami Cancer Institute (MCI)
  2. 2. Life expectancy ≥ 6 months
  3. 3. Willingness to participate in ongoing registration study
  1. 1. Patients receiving radiotherapy to the brain for functional disease (arteriovenous malformations, trigeminal neuralgia, essential tremors, etc.)
  2. 2. Pediatric patients (\<18 years old), pregnant women, and prisoners.

Contacts and Locations

Study Contact

Rupesh R Kotecha
CONTACT
17865962000
rupeshk@baptisthealth.net

Principal Investigator

Rupesh R Kotecha, MD
PRINCIPAL_INVESTIGATOR
Miami Cancer Institute

Study Locations (Sites)

Miami Cancer Institute
Miami, Florida, 33176
United States

Collaborators and Investigators

Sponsor: Baptist Health South Florida

  • Rupesh R Kotecha, MD, PRINCIPAL_INVESTIGATOR, Miami Cancer Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-11-30
Study Completion Date2027-11

Study Record Updates

Study Start Date2021-11-30
Study Completion Date2027-11

Terms related to this study

Keywords Provided by Researchers

  • Neurocognitive
  • Brainlab Cognition app

Additional Relevant MeSH Terms

  • Neurocognitive Disorders